Bing-He Xu

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial

Xi-Chun Hu, Jian Zhang, Bing-He Xu et al. · The Lancet Oncology · 2015 · 285 citations

Medicine, Oncology, Pharmacology +15

Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients

Bing-He Xu, Ze-Fei Jiang, Daniel T. T. Chua et al. · Chinese Journal of Cancer · 2011 · 45 citations · Full text

Medicine, Oncology, Pharmacology +16

Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial

Jian-Wei Li, Guang‐Yu Liu, Ya-Jie Ji et al. · Cancer Management and Research · 2018 · 12 citations · Full text

Medicine, Oncology, Pharmacology +16